CapsoVision, Inc. (CV)

Market Closed

27 Jul, 20:00

NASDAQ (CM)

6. 61

+0.12

+1.849%

324.26M Market Cap

- P/E Ratio

- Div Yield

81,835 Volume

- Eps

$ 6.49

Previous Close

Investors:

Add Transaction

Day Range

6.54 6.78

Year Range

3.43 15.37

Want to track CV and more in your Portfolio? 🎯

Get Started For Free

CapsoVision Q1 Earnings Call Highlights

CapsoVision NASDAQ: CV reported steady first-quarter revenue and said it continues to advance artificial intelligence and capsule endoscopy programs aimed at expanding the use of its gastrointestinal imaging platform.

Marketbeat | 2 months ago

CapsoVision, Inc. (CV) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago

CapsoVision, Inc. (CV) Q4 2025 Earnings Call Transcript

Seekingalpha | 4 months ago

CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus

CV seeks FDA clearance to add AI-based reading to CapsoCam Plus to boost diagnostic accuracy and streamline reviews.

Zacks | 6 months ago

Blog Affiliate Program About Terms Privacy Help Contact Us